Semaglutide GLP-1, a once-weekly injectable medication, has become a focal point of discussion at our Set Point Medical Weight Loss Clinic, primarily for its potential weight loss benefits in adults who are overweight or obese
Patients should always inform their healthcare providers about any medications theyre on
A spokeswoman, Kathleen Makela, said Point32Health, which operates Harvard Pilgrim Health Plan and Tufts Health Plan, had no immediate plans to restrict GLP-1 coverage for weight loss
Semaglutide demonstrated a favourable safety profile consistent with its established use in T2D and obesity across both phase 2 and phase 3 studies
We serve patients from Webster TX, Bacliff TX, Dickinson TX, Seabrook TX, League City TX, Clear Lake City TX, and surrounding areas